GlobeNewswire•4 days agoPasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva (FOP)REGN0.16%
Zacks•10 days agoShould First Trust Small Cap Value AlphaDEX ETF (FYT) Be on Your Investing Radar?FYT0.00%